Extendicare Inc. Q2 2026 Earnings Recap

Shares dropped 4.9% following earnings as investors reacted negatively to margin compression in the home health care segment amid rapid volume growth and no rate increases in Ontario.

Key Takeaways

• Consolidated Q2 revenue rose 59.4% to $611 million, driven by acquisitions including CBI and Closing the Gap, and organic growth in home health care.
• Adjusted EBITDA increased 71.7% year over year to $68.3 million, reflecting acquisition activity and organic expansion.
• Home health care volumes grew 133% year over year, with same-store ADV up 31.7%, but NOI margins declined 60 basis points due to increased investments and lack of 2026 Ontario rate increases.
• Long term care segment showed solid occupancy and funding enhancements supporting NOI growth of $5.7 million and trailing 12-month margins of 11.8%.
• AFFO per share rose 52.9% to $0.448, though this was partly offset by elevated stock compensation costs related to board retirements.